All Pharma News
Gelesis’ Oral Treatment for Weight Management Showed Real-World Effectiveness

Gelesis’ Oral Treatment for Weight Management Showed Real-World Effectiveness
BUSINESSWIRE
26 Jun 2023
Share Share
Gelesis Reports Fourth Quarter and Full Year 2022 Results

Gelesis Reports Fourth Quarter and Full Year 2022 Results
BUSINESSWIRE
28 Mar 2023
Share Share
Gelesis to Participate in the 25th Annual ICR Conference

Gelesis to Participate in the 25th Annual ICR Conference
BUSINESSWIRE
05 Jan 2023
Share Share
Gelesis Receives Notice of NYSE Market Capitalization Rule Non-Compliance

Gelesis Receives Notice of NYSE Market Capitalization Rule Non-Compliance
BUSINESSWIRE
18 Nov 2022
Share Share
Gelesis Reports Third Quarter 2022 Results

Gelesis Reports Third Quarter 2022 Results
BUSINESSWIRE
14 Nov 2022
Share Share
Gelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-Compliance

Gelesis Receives Notice of NYSE Trading Share Price Listing Rule Non-Compliance
BUSINESSWIRE
04 Nov 2022
Share Share
Dr. Frank Greenway to Present Data from LIGHT-UP Study Gelesis’ Oral Hydrogel

Dr. Frank Greenway to Present Data from LIGHT-UP Study Gelesis’ Oral Hydrogel
BUSINESSWIRE
01 Nov 2022
Share Share
Gelesis Reports Second Quarter 2022 Results

Gelesis Reports Second Quarter 2022 Results
BUSINESSWIRE
15 Aug 2022
Share Share
Gelesis to Report Second Quarter 2022 Financial Results on August 15, 2022

Gelesis to Report Second Quarter 2022 Financial Results on August 15, 2022
BUSINESSWIRE
04 Aug 2022
Share Share
Gelesis Announces Additional $15M Pre-Order for Plenity

Gelesis Announces Additional $15M Pre-Order for Plenity
BUSINESSWIRE
21 Jun 2022
Share Share